Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиГодовой отчет за 2024 год
добавлен 04.03.2025
Y-mAbs Therapeutics Мультипликаторы 2011-2025 | YMAB
Мультипликаторы по годам Y-mAbs Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-7.3 | -33.8 | -1.4 | -7.1 | -14.1 | -14.7 | -13.5 | - | - | - | - | - | - | - |
P/S |
2.5 | 8.5 | 2.0 | 11.3 | 81.4 | - | - | - | - | - | - | - | - | - |
EPS |
-0.7 | -0.5 | -2.2 | -1.3 | -3.0 | -2.3 | -1.5 | -1.0 | - | - | - | - | - | - |
EV (Enterprise Value) |
177 млн | 672 млн | 60.2 млн | 244 млн | 1.6 млрд | 998 млн | 447 млн | -80.5 млн | 5.2 млн | - | - | - | - | - |
EBITDA per Share |
-0.69 | -0.57 | -2.15 | -2.66 | -2.97 | -2.35 | -1.5 | - | - | - | - | - | - | - |
EV/EBITDA |
-2.1 | -13.2 | -11.8 | -10.1 | - | - | - | - | - | - | - | |||
PEG |
0.65 | 8.41 | - | 0.3 | 0.27 | 0.08 | - | - | - | - | - | - | - | |
P/B |
2.4 | 7.2 | 1.2 | 2.2 | 16.0 | 6.0 | 4.2 | - | - | - | - | - | - | - |
P/CF |
-13.8 | -26.6 | -1.8 | -3.8 | -18.5 | -15.7 | -14.1 | - | - | - | - | - | - | - |
ROE % |
-32.24 | -21.22 | -87.50 | -30.69 | -112.76 | -40.74 | -30.79 | - | - | - | - | - | - | - |
ROA % |
-24.74 | -16.76 | -67.56 | -25.98 | -90.37 | -37.45 | -28.48 | - | - | - | - | - | - | - |
ROCE % |
-33.91 | -25.42 | -86.81 | -64.09 | -106.60 | -40.93 | -30.27 | - | - | - | - | - | - | - |
Current Ratio |
4.3 | 4.8 | 4.4 | 6.5 | 6.3 | 15.6 | 16.6 | - | - | - | - | - | - | - |
DSO |
87.7 | 75.3 | 56.6 | 40.3 | - | - | - | - | - | - | - | - | - | - |
DIO |
149.4 | 188.9 | 298.5 | 436.6 | - | - | - | - | - | - | - | - | - | - |
DPO |
154.8 | 324.9 | 677.7 | 1815.8 | 1552.8 | - | - | - | - | - | - | - | - | - |
Операционный цикл |
237.1 | 264.2 | 355.1 | 476.9 | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
82.3 | -60.7 | -322.6 | -1338.9 | -1552.8 | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Y-mAbs Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.16 | -0.21 | -0.15 | - | -0.18 | -0.14 | -0.15 | - | -0.63 | -0.94 | -0.64 | - | -0.66 | -0.53 | 0.8 | -0.48 | -0.82 | -1.01 | -0.66 | -0.6 | -0.7 | -0.53 | -0.47 | -0.42 | -0.42 | -0.39 | -0.28 | -0.44 | -0.21 | -0.18 | -0.16 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.15 | - | - | - | -0.17 | - | -0.58 | -0.91 | -0.63 | - | -0.65 | -0.52 | -0.67 | - | -0.81 | -1.01 | -0.67 | - | -0.71 | -0.54 | -0.47 | -0.41 | -0.42 | -0.38 | -0.28 | - | -0.21 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-31.69 | -31.86 | -28.17 | -19.68 | -45.19 | -62.97 | -88.25 | -74.64 | -88.33 | -76.50 | -54.99 | -10.23 | -29.06 | -46.40 | -74.77 | -112.76 | -105.55 | -86.56 | -57.46 | -40.74 | -39.11 | -35.21 | -33.48 | -30.79 | -32.05 | -28.58 | -21.25 | -15.92 | -4.66 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-23.60 | -23.82 | -22.16 | -15.42 | -34.55 | -47.66 | -67.80 | -58.72 | -70.74 | -63.64 | -47.58 | -8.71 | -23.81 | -36.64 | -58.40 | -90.37 | -85.97 | -72.16 | -49.91 | -37.45 | -36.01 | -32.48 | -30.92 | -28.48 | -29.27 | -25.91 | -19.12 | -14.20 | -4.15 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-34.24 | -32.71 | -29.34 | -21.59 | -45.71 | -62.08 | -85.58 | -72.10 | -85.71 | -75.22 | -54.51 | -34.51 | -53.50 | -70.73 | -99.25 | -113.32 | -106.28 | -87.68 | -58.83 | -41.73 | -39.80 | -35.68 | -33.61 | -30.76 | -32.03 | -28.59 | -21.29 | -15.97 | -4.68 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
4.2 | 3.0 | 5.1 | 4.8 | 4.5 | 4.8 | 4.6 | 4.4 | 4.0 | 4.9 | 5.7 | 6.5 | 8.2 | 10.3 | 12.1 | 5.0 | 5.0 | 5.0 | 5.0 | 12.4 | 12.4 | 12.4 | 12.4 | 13.3 | 13.3 | 13.3 | 13.3 | 9.2 | 9.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
104.1 | 85.6 | 98.5 | - | 84.8 | 83.2 | 70.4 | - | 59.9 | 69.9 | 74.1 | - | 80.3 | 60.5 | 50.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
366.4 | 256.5 | 294.0 | - | 216.3 | 138.7 | 342.7 | - | 240.3 | 495.6 | 276.6 | - | 714.0 | 1100.7 | 493.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
366.7 | 256.1 | 278.2 | - | 261.3 | 158.0 | 504.2 | - | 461.1 | 1038.7 | 703.0 | - | 1478.8 | 3044.6 | 7807.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
470.5 | 342.1 | 392.5 | - | 301.0 | 221.8 | 413.1 | - | 300.2 | 565.4 | 350.7 | - | 794.3 | 1161.2 | 543.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
103.8 | 86.0 | 114.3 | - | 39.7 | 63.9 | -91.1 | - | -160.9 | -473.2 | -352.3 | - | -684.5 | -1883.4 | -7263.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD